These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 22140653)
61. Rapamycin prevents cadmium-induced neuronal cell death via targeting both mTORC1 and mTORC2 pathways. Xu C; Liu C; Liu L; Zhang R; Zhang H; Chen S; Luo Y; Chen L; Huang S Neuropharmacology; 2015 Oct; 97():35-45. PubMed ID: 26002629 [TBL] [Abstract][Full Text] [Related]
62. Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism. Yu S; Shen G; Khor TO; Kim JH; Kong AN Mol Cancer Ther; 2008 Sep; 7(9):2609-20. PubMed ID: 18790744 [TBL] [Abstract][Full Text] [Related]
64. PI3K and mTOR signaling pathways in cancer: new data on targeted therapies. Willems L; Tamburini J; Chapuis N; Lacombe C; Mayeux P; Bouscary D Curr Oncol Rep; 2012 Apr; 14(2):129-38. PubMed ID: 22350330 [TBL] [Abstract][Full Text] [Related]
65. Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibition. Shi H; Kong X; Ribas A; Lo RS Cancer Res; 2011 Aug; 71(15):5067-74. PubMed ID: 21803746 [TBL] [Abstract][Full Text] [Related]
66. Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cells. Curless BP; Uko NE; Matesic DF Invest New Drugs; 2019 Oct; 37(5):902-911. PubMed ID: 30542835 [TBL] [Abstract][Full Text] [Related]
67. Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. Ho AL; Musi E; Ambrosini G; Nair JS; Deraje Vasudeva S; de Stanchina E; Schwartz GK PLoS One; 2012; 7(7):e40439. PubMed ID: 22808163 [TBL] [Abstract][Full Text] [Related]
68. The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2. Chen CH; Sarbassov dos D J Biol Chem; 2011 Nov; 286(46):40386-94. PubMed ID: 21965657 [TBL] [Abstract][Full Text] [Related]
69. New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs). Feldman ME; Shokat KM Curr Top Microbiol Immunol; 2010; 347():241-62. PubMed ID: 20549474 [TBL] [Abstract][Full Text] [Related]
70. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1. Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175 [TBL] [Abstract][Full Text] [Related]
76. Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle. White JP; Gao S; Puppa MJ; Sato S; Welle SL; Carson JA Mol Cell Endocrinol; 2013 Jan; 365(2):174-86. PubMed ID: 23116773 [TBL] [Abstract][Full Text] [Related]
77. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
78. Okadaic acid induces Akt hyperphosphorylation and an oxidative stress-mediated cell death in serum starved SK-N-SH human neuroblastoma cells that are augmented by rapamycin. Edelstein J; Rockwell P Neurosci Lett; 2012 Dec; 531(2):74-9. PubMed ID: 23127854 [TBL] [Abstract][Full Text] [Related]
79. The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. Tooley AS; Kazyken D; Bodur C; Gonzalez IE; Fingar DC J Biol Chem; 2021 Aug; 297(2):100942. PubMed ID: 34245780 [TBL] [Abstract][Full Text] [Related]